Leslie GJ - Search Results

1

A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection.

Lawrence SP, Elser SE, Torben W, Blair RV, Pahar B, Aye PP, Schiro F, Szeltner D, Doyle-Meyers LA, Haggarty BS, Jordan APO, Romano J, Leslie GJ, Alvarez X, O'Connor DH, Wiseman RW, Fennessey CM, Li Y, Piatak M Jr, Lifson JD, LaBranche CC, Lackner AA, Keele BF, Maness NJ, Marsh M, Hoxie JA. Lawrence SP, et al. Among authors: leslie gj. PLoS Pathog. 2022 Jun 17;18(6):e1010507. doi: 10.1371/journal.ppat.1010507. eCollection 2022 Jun. PLoS Pathog. 2022. PMID: 35714165 Free PMC article.

2

Tetherin downmodulation by SIVmac Nef lost with the H196Q escape variant is restored by an upstream variant.

Schouest B, Leslie GJ, Hoxie JA, Maness NJ. Schouest B, et al. Among authors: leslie gj. PLoS One. 2020 Aug 7;15(8):e0225420. doi: 10.1371/journal.pone.0225420. eCollection 2020. PLoS One. 2020. PMID: 32764749 Free PMC article.

3

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.

Laakso MM, Lee FH, Haggarty B, Agrawal C, Nolan KM, Biscone M, Romano J, Jordan AP, Leslie GJ, Meissner EG, Su L, Hoxie JA, Doms RW. Laakso MM, et al. Among authors: leslie gj. PLoS Pathog. 2007 Aug 24;3(8):e117. doi: 10.1371/journal.ppat.0030117. PLoS Pathog. 2007. PMID: 17722977 Free PMC article.

4

Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4.

Del Prete GQ, Haggarty B, Leslie GJ, Jordan AP, Romano J, Wang N, Wang J, Holmes MC, Montefiori DC, Hoxie JA. Del Prete GQ, et al. Among authors: leslie gj. J Virol. 2009 Oct;83(19):9911-22. doi: 10.1128/JVI.00533-09. Epub 2009 Jul 15. J Virol. 2009. PMID: 19605489 Free PMC article.

5

Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.

Swanstrom AE, Haggarty B, Jordan APO, Romano J, Leslie GJ, Aye PP, Marx PA, Lackner AA, Del Prete GQ, Robinson JE, Betts MR, Montefiori DC, LaBranche CC, Hoxie JA. Swanstrom AE, et al. Among authors: leslie gj. J Virol. 2016 Apr 29;90(10):4966-4980. doi: 10.1128/JVI.02851-15. Print 2016 May 15. J Virol. 2016. PMID: 26937037 Free PMC article.

6

Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.

Del Prete GQ, Leslie GJ, Haggarty B, Jordan AP, Romano J, Hoxie JA. Del Prete GQ, et al. Among authors: leslie gj. J Virol. 2010 Sep;84(17):8777-89. doi: 10.1128/JVI.00333-10. Epub 2010 Jun 23. J Virol. 2010. PMID: 20573813 Free PMC article.

7

Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.

Leslie GJ, Wang J, Richardson MW, Haggarty BS, Hua KL, Duong J, Secreto AJ, Jordon AP, Romano J, Kumar KE, DeClercq JJ, Gregory PD, June CH, Root MJ, Riley JL, Holmes MC, Hoxie JA. Leslie GJ, et al. PLoS Pathog. 2016 Nov 17;12(11):e1005983. doi: 10.1371/journal.ppat.1005983. eCollection 2016 Nov. PLoS Pathog. 2016. PMID: 27855210 Free PMC article.

8

Characterization of a human immunodeficiency virus type 1 V3 deletion mutation that confers resistance to CCR5 inhibitors and the ability to use aplaviroc-bound receptor.

Nolan KM, Del Prete GQ, Jordan AP, Haggarty B, Romano J, Leslie GJ, Hoxie JA. Nolan KM, et al. Among authors: leslie gj. J Virol. 2009 Apr;83(8):3798-809. doi: 10.1128/JVI.01751-08. Epub 2009 Feb 4. J Virol. 2009. PMID: 19193800 Free PMC article.

9

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Lin G, Simmons G, Pöhlmann S, Baribaud F, Ni H, Leslie GJ, Haggarty BS, Bates P, Weissman D, Hoxie JA, Doms RW. Lin G, et al. Among authors: leslie gj. J Virol. 2003 Jan;77(2):1337-46. doi: 10.1128/jvi.77.2.1337-1346.2003. J Virol. 2003. PMID: 12502850 Free PMC article.

10

Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.

Lin G, Bertolotti-Ciarlet A, Haggarty B, Romano J, Nolan KM, Leslie GJ, Jordan AP, Huang CC, Kwong PD, Doms RW, Hoxie JA. Lin G, et al. Among authors: leslie gj. J Virol. 2007 Sep;81(18):9956-66. doi: 10.1128/JVI.00385-07. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page